What's Happening at Pfizer Right Now? 8 comments
September 26, 2008
| about: PFE
-
Font Size:
-
Print
- TweetThis
I'm hearing reports that Pfizer (PFE) is telling employees in various therapeutic areas right now that there will be deep cuts coming, and that more details will be coming out in about two weeks (individual-level layoff notices, etc.). I gather that obesity research is being hit hard, and some others as well - but any details from people in a position to know would be appreciated.
This is a heck of a time to be laid off, that's for sure. Here's hoping that things aren't as bad as I'm hearing...
Related Articles
|



























This article has 8 comments:
Layoffs are just the entree.
It won't stop there.
Time to buy big on Benitec and Tekmira.
It is noteworthy that Roche is now in talks with Rosetta Genomics (ROSG) after having already struck a deal with Alnylam.
Makes PFE look like a sloth.
Roche mulls Rosetta bid
The pharma giant may invest in or acquire the microRNA diagnostics developer.
Gali Weinreb 24 Sep 08 12:12
Roche Holding AG (SWX: RO), which is already is involved in an expensive takeover bid for Genentech Inc. (NYSE: DNA), has also begun deliberating a combination with Israeli microRNA-based diagnostics and therapeutics developer Rosetta Genomics Ltd. (Nasdaq:ROSG). Sources inform ''Globes'' that Roche representatives visited Rosetta's offices and negotiations for a possible investment or takeover are underway. Talks are in the early stage.
Rosetta declined to comment on the report.
jegan ;-)